ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Controlling Diabetes May Cut Liver Cancer Risk, Study Finds

April 30, 2010

In Brief: Clinton Appoints Breast Cancer coalition’s Fran Visco to President’s Cancer Panel

May 21, 1993

AACR Cancels $7 Million Annual Meeting, Citing Fear of SARS in Toronto

April 4, 2003

HCFA Renamed In HHS Effort At Medicare, Medicaid Reform.

June 22, 2001

ACS Reports Breast Cancer Incidence At All Time High

January 23, 1987

In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule

November 5, 1976